HOLLYWOOD, Fla., Feb. 6, 2008 (PRIME NEWSWIRE) -- STARLIMS Technologies Ltd.
(Nasdaq:LIMS), a leading provider of laboratory information management systems
(LIMS), today announced that its STARLIMS Version 10 software was selected in
September 2007 by Rutgers University Cell and DNA Repository (RUCDR). The
entirely web-based STARLIMS system will enable hundreds of research sites to
obtain bio-banking data in real time, using a standard web browser.
World-leading Repository Serves over 500 Research Sites Worldwide
RUCDR is the largest university-based cell and DNA repository in the world.
RUCDR has been designated as the Center for Collaborative Genetic Studies for
the National Institute of Mental Health (NIMH), the Genetics Repository for the
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the
Center for Genetic Studies for the National Institute on Drug Abuse (NIDA) and
the National Cell Repository for the Collaborative on the Genetics of Alcoholism
funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA). In
addition, RUCDR collaborates with many other federal, state and private research
organizations, serving over 500 research sites worldwide.
Streamlined Sample Tracking and Web-based Information Access
"RUCDR has consistently been at the frontier of new technologies, and leveraging
the web to facilitate remote collaboration in the research community is an
enormous step forward in the bio-banking sector," said Jeff Ferguson, COO of
STARLIMS.
STARLIMS solutions for bio-sample repositories automate molecular based testing
workflows, streamlining sample tracking and management. At the same time,
STARLIMS puts lab information resources on a single globally accessible web
platform. Bio-repositories such as RUCDR can give authorized researchers
real-time data access to a searchable database of annotated specimen
information, maximizing the value of the stored samples.
Cutting-edge Technology Supports Rapid Growth
"RUCDR experienced a ten-fold increase in sample acquisition in the years
1998-2004, and has continued growing steadily since then. To grow at such rates,
while continuing to provide the highest levels of sample quality, technical
consultation and logistical support, we must consistently choose the most
advanced technologies," said Dr. Jay A Tischfield, Scientific Director of RUCDR.
"Implementing STARLIMS's web-based software is part of our long-term vision of
providing timely information to all our project sites, and doing everything in
our power to promote collaboration in the research community."
About RUCDR
Located on the Busch Campus of Rutgers University, Piscataway, New Jersey, the
Rutgers University Cell and DNA Repository (RUCDR) is the largest
university-based repository in the world. RUCDR plays a key role in research
aimed at understanding the genetic causes of common, complex diseases. RUCDR
activities will enable gene discovery leading to diagnoses, treatments and,
eventually, cures for these diseases. RUCDR assists researchers throughout the
world by providing the highest quality biomaterials, technical consultation, and
logistical support. Please see http://www.rucdr.org/index.html for more
information.
About STARLIMS
STARLIMS Technologies Ltd. (Nasdaq:LIMS) is a leading provider of laboratory
information management systems (LIMS), with over 20 years of LIMS experience.
The company's flagship product, STARLIMS(r), improves the reliability of
laboratory sampling processes, supports compliance with domestic and
international regulations and industry standards, and provides comprehensive
reporting, monitoring and analysis capabilities. STARLIMS software is used for
quality assurance and control, testing and monitoring, and research and
development in government, manufacturing and life sciences organizations. With
operations in the United States, Canada, the United Kingdom, Israel and Hong
Kong, the company serves over 500 organizations in 40 countries. Please see
www.starlims.com for more information.
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Forward-looking statements
involve known and unknown risks and uncertainties which could cause the actual
results, performance or achievements of the Company to be materially different
from those which may be expressed or implied by such statements, including,
among others, changes in general economic and business conditions, changes in
demand for products and services, the timing and amount or cancellation of
orders, loss of market share and other risks detailed from time to time in
STARLIMS's filings from time to time with the Securities and Exchange
Commission. Such filings contain and identify these and other important factors
that could cause actual results to differ materially from those contained in our
projections or forward-looking statements. Shareholders and other readers are
cautioned not to place undue reliance on these forward-looking statements, which
speak only as of the date on which they are made. We undertake no obligation to
update publicly or revise any forward-looking statement.
-0-
CONTACT: STARLIMS Technologies Ltd.
Tamar Harris, Director of Corporate Communications
(604) 961-6121
tamar.harris@starlims.com
Integrated Corporate Relations (ICR)
Michael Kern, Investor Relations
(617) 956-6731
michael.kern@icrinc.com
